A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers
Public ClinicalTrials.gov record NCT05790681. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study Investigating the Pharmacokinetic Properties of Insulin Icodec in Children and Adolescents With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Insulin icodec is a new medicine which is under development for use in humans and is not yet available at the pharmacy. It is being developed for the treatment of diabetes, a condition that causes high blood sugar levels. Insulin icodec will be investigated in participants with type 2 diabetes. Participant will get one dose of insulin icodec, which will be administered in the afternoon or evening of the day of dosing. The study will last for about 8 weeks. Insulin icodec will be injected into a skin fold with a small needle (subcutaneous application) using a pen injector prefilled with a volume of 3 milliliter (mL) (a little less than a quarter of a teaspoonful). The amount of insulin icodec participant will receive depends on participant's body weight. Participant must not participate if participant meets certain conditions called exclusion criteria, such as an age of above 18 years when the informed consent is signed or has serious health conditions. Female participant cannot take part if she is pregnant, breast-feeding or planning to become pregnant during the study period.
Study identification
- NCT ID
- NCT05790681
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 25, 2023 (Actual)
- Primary completion
- Feb 8, 2024 (Actual)
- Completion
- Feb 8, 2024 (Actual)
- Last update posted
- Apr 9, 2026
2023 – 2024
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hosp-Los Angeles | Los Angeles | California | 90027 | — |
| Children's Hospital Los Angeles - Endocrinology | Los Angeles | California | 90027 | — |
| Yale New Haven Hospital, Hospital Research Unit | New Haven | Connecticut | 06510 | — |
| Yale University | New Haven | Connecticut | 06511 | — |
| Nemours Children's Health | Jacksonville | Florida | 32207 | — |
| Nemours Chld Clnc Jacksonville | Jacksonville | Florida | 32207 | — |
| Childrens Hospital of Chicago | Chicago | Illinois | 60611 | — |
| University Of Iowa_Iowa City | Iowa City | Iowa | 52242 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Pennington Biom Res Ctr | Baton Rouge | Louisiana | 70808 | — |
| John Hopkins Univ Hosp | Baltimore | Maryland | 21287 | — |
| UBMD Pediatrics | Buffalo | New York | 14203 | — |
| UBMD Peds-Div of Endo/Diabetes | Buffalo | New York | 14203 | — |
| Cincinnati Child's Hsp Med Ctr | Cincinnati | Ohio | 45229 | — |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | — |
| Children's Hosp Of Phil | Philadelphia | Pennsylvania | 19104 | — |
| Children's Hospital of Pittsburgh Of UPMC | Pittsburgh | Pennsylvania | 15224 | — |
| Texas Tech University HSC | Amarillo | Texas | 79106 | — |
| NE Clin Res of San Antonio | Schertz | Texas | 78154 | — |
| University of Virginia Clinical Research Unit | Charlottesville | Virginia | 22908 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05790681, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05790681 live on ClinicalTrials.gov.